ADCT

Adc Therapeutics Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 0/10
Adc Therapeutics sales and earnings growth
ADCT Growth
Good
  • Revenue Y/Y↑ 14.85%
  • EPS Y/Y↑ 30.86%
  • FCF Y/Y↓ -12.89%
Adc Therapeutics gross and profit margin trends
ADCT Profitability
Fair
  • Gross margin ↑ 92.90%
  • EPS margin↓ -175.30%
  • ROIC 5Y↓ -84.94%
Adc Therapeutics net debt vs free cash flow
ADCT Risk
Great
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1.7

Adc Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗